Top 10 Fast-growings companies in PCSK9 Inhibitors by Most Patent Filing In 1 Year in the world in 2019 – Discovery

Free Trial

The PCSK9 Inhibitors top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 1 Year PCSK9 Inhibitors Fast-growings in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	Regeneron Pharmaceuticals, Inc.	New York, United States	Monoclonal antibody,Clinical trial,Cholesterol, ...[+2]	Patent: 14
2	Novartis AG	Basel-Stadt, Switzerland	Dosage form,Health care,Medicine, ...[+2]	Patent: 11
3	The Brigham & Women's Hospital, Inc.	Massachusetts, United States	Health care,Mitral valve surgery,Health equity, ...[+2]	Patent: 5
4	Duke University	North Carolina, United States	Style guide,Typeface,Medicine, ...[+2]	Patent: 4
5	Amgen, Inc.	California, United States	Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER, ...[+2]	Patent: 3
6	Ra Pharmaceuticals, Inc.	Massachusetts, United States	Medicine,Health care,Drug class, ...[+2]	Patent: 3
7	Shenzhen Salubris Pharmaceuticals Co., Ltd.	Guangdong Sheng, China	Medicine,Cefaclor,Antithrombotic, ...[+2]	Patent: 2
8	Ningxia Ruyi Technology Fashion Industry Co., Ltd.	China		Patent: 2
9	Institut National de la Santé et de la Recherche Médicale	Île-de-France, France	Public health,Genomics,Antisense therapy, ...[+2]	Patent: 2
10	Guangzhou Bosma Optoelectronic Technology Co. Ltd.	Guangdong Sheng, China	Computer hardware,Electronics,Semiconductor, ...[+1]	Patent: 2